Notably, our data also found that there was no significant difference in the diagnostic performance of the AFP/(ALT × AST) ratio in patients with different ALT levels, suggesting that the AFP/(ALT × AST) ratio could avoid the influences of hepatic inflammatory factors in detecting HCC. Here, AFP is linked to hepatocellular carcinoma.